Loading clinical trials...
Loading clinical trials...
Study of the Safety and Effectiveness of the Ologen(OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery
Conditions
Interventions
ologen™ Collagen matrix implantation in glaucoma filtering surgery
Locations
1
China
Shanghai sixth People's Hospital
Shanghai, China
Start Date
February 1, 2007
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2011
Last Updated
October 7, 2011
NCT07244276
NCT05456425
NCT07458126
NCT04683159
NCT04419038
NCT04385446
Lead Sponsor
Pro Top & Mediking Company Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions